OXA1L

Across TCGA pan-cancer cohorts, OXA1L RNA differs between tumor and matched normal tissue in 11 of 18 cancer types tested, making tumor–normal expression one of OXA1L’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where OXA1L RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OXA1L is over-expressed in tumor.

KIRC, LIHC, and KIRP are the cancer types where OXA1L tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OXA1L RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Female	All	+0.507	<.001	11	view →
LIHC	Female	II,III,IV	+1.311	<.001	9	view →
KIRP	All	II,III,IV	+0.684	<.001	9	view →
LUAD	All	II,III,IV	+0.283	.001	6	view →
CHOL	All	All	+1.127	<.001	5	view →
KICH	All	II,III,IV	+0.407	.016	5	view →
BLCA	All	All	+0.236	.035	3	view →
LUSC	Male	All	+0.213	.010	2	view →
PRAD	All	All	+0.115	.030	2	view →
ESCA	All	All	+0.487	.021	1	view →
STAD	All	II,III,IV	+0.366	.012	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 11 strongest of 11 lineages.

OXA1L–KIRC

Open the KIRC breakdown →